Vitamin D metabolites and analogs in the treatment of osteoporosis

CMAJ. Canadian Medical Association Journal

Volumn 155, Issue 7, 1996, Pages 955-961

  Jones, Glenville ^a   Hogan, David B ^b   Yendt, Edmund ^c   Hanley, David A ^b   Bowyer, Mary ^d  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

^d Osteoporosis Society of Canada   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CORTICOSTEROID; HYDROXYCOLECALCIFEROL; VITAMIN D DERIVATIVE; DRUG DERIVATIVE; VITAMIN D;

ARTICLE; BONE DENSITY; BONE MASS; BONE MINERAL; CALCIUM INTAKE; CANADA; CLINICAL TRIAL; DRUG MONITORING; FRACTURE; HIP FRACTURE; HUMAN; HYPERCALCEMIA; HYPERCALCIURIA; JAPAN; KIDNEY CALCIFICATION; META ANALYSIS; NEPHROLITHIASIS; NUTRITION; OSTEOPOROSIS; QUALITY OF LIFE; VERTEBRA FRACTURE; AGED; BONE; CHEMICALLY INDUCED DISORDER; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; DRUG EFFECT; FEMALE; MALE; MEDICAL SOCIETY; METABOLISM; MIDDLE AGED; OSTEOBLAST; OSTEOCLAST;

AGED; BONE AND BONES; CALCITRIOL; CANADA; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOBLASTS; OSTEOCLASTS; OSTEOPOROSIS; SOCIETIES, MEDICAL; VITAMIN D;

EID: 0030267620     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. 1. Biochemistry 1968;7:3317-22.
2. Fraser DR, Kodicek F. Unique biosynthesis by kidney of a biologically active vitamin D metabolite [letter]. Nature 1970;228:764-6.
3. Jones G, Trafford DJH, Hollis BW, Makin HLJ. Vitamin D: cholecalciferol, ergocalciferol and hydroxylated metabolites. In: Nelis HJ, Lambert WE, DeLeenheer AP, editors. Modern Chromatographic Analysis of Vitamins, 2nd ed [Chromatographic Science Series]. New York: Marcel Dekker, 1992;30:73-151.
4. Haussler MR. Vitamin D receptors: nature and function. Annu Rev Nutr 1986;6:527-62.
5. Jones G, Calverley MJ. A dialogue on analogues: newer vitamin-D drugs for use in bone disease, psoriasis, and cancer. Trends Endocrinol Metab 1993;3:297-303.
6. DeLuca HF. The vitamin D story: a collaborative effort of basic science and clinical medicine. FASEB J 1988;2:224-36.
7. 1 receptors: structure and function in transcription. Annu Rev Nutr 1991;11:189-216.
8. 1 promotes fusion of mouse alveolar macrophages both by a direct mechanism and by a spleen cell-mediated indirect mechanism. Proc Natl Acad Sci U S A 1983;80:5583-7.
9. 1. Proc Natl Acad Sci U S A 1983;80:5907-11.
10. 1 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab 1983;57:1308-10.
11. 1: a novel immunoregulatory hormone. Science 1984;224:1438-40.
12. 1 interaction with dexamethasone and retinoic acid: effects on procollagen messenger ribonucleic acid levels in rat osteoblast-like cells. Mol Endocrinol 1989;3:97-104.
13. 1 increases bone alkaline phosphatase isoenzyme levels in human osteogenic sarcoma cells. J Biol Chem 1983;258:6219-25.
14. 1 on its receptor mRNA levels and osteocalcin synthesis in human osteosarcoma cells. Biochim Biophys Acta 1990;1048:30-7.
15. 1 enhances 12-O-tetradecanoylphorhol-13-acetate-induced tumorigenic transformation and osteopontin expression in mouse JB6 epidermal cells. Cancer Res 1993;53:2217-20.
16. 1 treatment of osteosarcoma cells. Calcif Tissue Int 1990;46:270-9.
17. Lian JB, Stein GS, Owen TA et al. Vitamin D regulation of the bone-specific osteocalcin gene is functionally related to osteoblast growth and differentiation. In: Norman AW, Bouillon R, Thomasset M, editors. Vitamin D: gene regulation, structure-function analytis and clinical application. Berlin: De Gruyter, 1991:12-20.
18. Chambers TJ. Cellular and hormonal interactions in bone resorption. In: Cohn DV, Martin TJ, Meunier PJ, editors. Calcium regulation and bone metabolism: basic and clinical aspects. vol 9. Amsterdam: Elsevier Science Publishers B.V. (Biomedical Division), 1987:335-42.
19. Zaidi M, Pazianas M, Shankar VS et al. Osteoclast function and its control. Exp Physiol 1993;78:721-39.
20. Lin HY, Harris TL, Flannery MS et al. Expression cloning of an adenylate cyclase-coupled calcitonin receptor. Science 1991;254:1022-4.
21. 1 receptors on osteoclasts of calcium-deficient chicken despite demonstrable receptors on circulating monocytes. J Clin Invest 1986;77:312-4.
22. DeLuca HF. The metabolism and functions of vitamin D. Adv Exp Med Biol 1986;196:361-75.
23. Suda T, Takahashi N, Abe E. Role of vitamin D in bone resorption. J Cell Biochem 1992;49:53-8.
24. 3. Proc Natl Acad Sci U S A 1981;78:4990-4.
25. 3 stimulates rat osteoblastic cells to release a soluble factor that increases osteoclastic bone resorption. J Clin Invest 1987;80:425-9.
26. Girasole G, Passeri G, Jilka RL, Manolagas SC. Interleukin-11: a new cytokine critical for osteoclast development. J Clin Invest 1994;93:1516-24.
27. Manolagas SC, Jilka RL. Bone marrow, cytokines and bone remodeling: emerging insights into the pathophysiology of osteoporosis. N Engl J Med 1995;332:305-11.
28. Baron R. Anatomy and ultrastructure of bone. In: Favus MJ, editor. Primer on the metabolic bone diseases and disorders of mineral metabolism. 2nd ed. New York: Raven Press, 1993:3-9.
29. Gallagher JC, Goldgar D. Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. A randomized controlled study. Ann Intern Med 1990;113:649-55.
30. Watson PH, Hanley DA. Parathyroid hormone: regulation of synthesis and secretion. Clin Invest Med 1993;16:58-77.
31. Bouillon R, Okamura WH, Norman AW. Structure-function relationships in the vitamin D endocrine system. Endocr Rev 1995;16:200-57.
32. 1 and calcium to prevent hip fractures in elderly women. N Engl J Med 1992;327:1637-42.
33. Morrison NA, Qi JC, Tokita A et al. Prediction of bone density from vitamin D receptor alleles. Nature 1994;367:284-7.
34. Hustmyer FG, Segre GV, Schipani E et al. BsmI polymorphism at the human parathyroid hormone/parathyroid hormone-related peptide receptor gene locus in Caucasians, blacks and Asians [abstract 319]. J Bone Miner Res 1993;8(suppl 1):S196.
35. Spector TD, Keen RW, Arden NK et al. Vitamin D receptor gene (VDR) alleles and bone density in postmenopausal women: a UK twin study [abstract 91]. J Bone Miner Res 1994;9(suppl 1):S143.
36. Bikle DD. Role of vitamin D, its metabolites, and analogs in the management of osteoporosis. Rheum Dis Clin North Am 1994;20:759-75.
37. Fujita T. Studies of osteoporosis in Japan. Metabolism 1990;39(4,suppl 1):39-42.
38. Itami Y, Fujita T, Inoue T et al. Effect of alphacalcidol on osteoporosis - multicenter double-blind study. J Clin Exp Med 1982;123:958-73.
39. 3. Bone Miner 1987;3:47-52.
40. Shiraki M, Ito H, Orimo H. The ultra long-term treatment of senile osteoporosis with 1 alpha-hydroxyvitamin D3. Bone Miner 1993;20:223-34.
41. Tilyard MW, Spears GF, Thomson J et al. Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med 1992;326:357-62.
42. Ross PD, Davis JW, Epstein RS et al. Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med 1991;114:919-23.
43. Ott SM, Chesnut CH III. Calcitriol treatment is not effective in postmenopausal osteoporosis. Ann Intern Med 1989;110:267-74.
44. Gallagher JC, Riggs BL, Recker RR et al. The effect of calcitriol on patients with postmenopausal osteoporosis with special reference to fracture frequency. Proc Soc Exp Biol Med 1989;191:287-92.
45. Aloia JF, Vaswani A, Yeh JK et al. Calcitriol in the treatment of postmenopausal osteoporosis. Am J Med 1988;84:401-8.
46. Sambrook P, Birmingham J, Kelly P et al. Prevention of corticosteroid osteoporosis: a comparison of calcium, calcitriol, and calcitonin. N Engl J Med 1993;328:1747-52.
47. 3 analogues for the treatment of osteoporosis. Osteoporos Int 1993;3:S190-3.